Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests
American Journal of Clinical Pathology · 2024
DOI: 10.1093/ajcp/aqae057 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2024. Verfasst von Stephanie A Hart und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, US. Hauptthemen laut MEDLINE: Centers for Medicare and Medicaid Services, U.S.. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
The goal of this study was to assess hospital compliance with federal price transparency mandates and barriers to pricing information in Tennessee.
Methods
All hospitals websites were queried for gross, cash, and BlueCross BlueShield of Tennessee prices for 8 high-frequency laboratory tests in 2 Centers for Medicare & Medicaid Services–mandated pricing sources: (1) a machine-readable file of all available services and (2) a consumer-friendly display of 300 shoppable services. Barriers, including click counts, data availability, and intrahospital price discrepancies, were noted.
Results
Of the 145 Tennessee hospitals assessed, 97.2% were noncompliant with the Centers for Medicare & Medicaid Services final rule. Subanalysis of available machine-readable files, price estimators, and shoppable services files demonstrated 49.6%, 95.1%, and 78.6% noncompliance, respectively. Barriers to pricing information included requiring protected health information (55.9%), missing at least 1 pricing source (7.6%), having no pricing sources available (6.2%), and involving more than 3 clicks to access the cash price in machine-readable files (54.1%) and price estimators (68.6%.) Average intrahospital discrepancy for basic metabolic panel cash prices across pricing sources was $101.30 (range, $0-1012.40).
Conclusions
Our study showed high levels of noncompliance with price transparency laws, inconsistent and inaccessible pricing, and continued challenges facing patients in Tennessee.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, US.
ORCID-Profile: Joesph R Wiencek
Zitieren
APA
Hart, S. A., Khan, A., Booth, G. S., & Wiencek, J. R. (2024). Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqae057
Vancouver
Hart SA, Khan A, Booth GS, Wiencek JR. Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests. American Journal of Clinical Pathology. 2024. doi:10.1093/ajcp/aqae057
BibTeX
@article{Hart2024,
author = {Hart, Stephanie A and Khan, Ayesha and Booth, Garrett S and Wiencek, Joesph R},
title = {Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests},
journal = {American Journal of Clinical Pathology},
year = {2024},
doi = {10.1093/ajcp/aqae057}
}
EUVIMED